Armata Pharmaceuticals, Inc. (ARMP) Payables (2016 - 2018)
Armata Pharmaceuticals' Payables history spans 6 years, with the latest figure at $714000.0 for Q3 2018.
- For Q3 2018, Payables fell 44.74% year-over-year to $714000.0; the TTM value through Sep 2018 reached $714000.0, down 44.74%, while the annual FY2017 figure was $578000.0, 76.48% down from the prior year.
- Payables for Q3 2018 was $714000.0 at Armata Pharmaceuticals, up from $682000.0 in the prior quarter.
- Across five years, Payables topped out at $3.2 million in Q2 2016 and bottomed at $578000.0 in Q4 2017.
- The 5-year median for Payables is $1.5 million (2015), against an average of $1.6 million.
- The largest annual shift saw Payables surged 114.51% in 2016 before it crashed 76.48% in 2017.
- A 5-year view of Payables shows it stood at $1.2 million in 2014, then soared by 30.33% to $1.5 million in 2015, then surged by 61.6% to $2.5 million in 2016, then plummeted by 76.48% to $578000.0 in 2017, then rose by 23.53% to $714000.0 in 2018.
- Per Business Quant, the three most recent readings for ARMP's Payables are $714000.0 (Q3 2018), $682000.0 (Q2 2018), and $810000.0 (Q1 2018).